richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
Published 5 years ago • 22 plays • Length 1:25
Download video MP4
Download video MP3
Similar videos
-
4:35
richard s. finn, md, elaborates on promising developments in the second-line treatment of hcc
-
1:30
richard finn, md, outlines the role of tace with systemic therapy in hcc
-
1:12
richard finn, md, shares his thoughts on the role of systemic therapy in hcc
-
1:00
richard finn, md, considers the effectiveness of sorafenib in newly diagnosed hcc
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
2:18
dr. richard finn on the difficulties of treating liver cancer
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
2:17
richard finn, md, speculates on combined checkpoint inhibition in hcc & biliary tract cancer
-
2:44
richard s. finn, md, regarding the updated imbrave150 data from asco gi 2021
-
2:56
dr. finn on role of lenvatinib in hcc treatment paradigm
-
42:44
update: biomarkers and treatments for hcc - richard finn - 10:10 am
-
2:18
dr. finn on biomarkers of response in hcc
-
13:51
how to integrate new agents in hcc: the role of tkis
-
55:56
“update on the treatment of hepatocellular carcinoma and current research” by richard lee, md
-
7:57
kynurenine/tryptophan is associated with biomarkers of neurodegenerative disease
-
2:08
dr. finn on studies of pembrolizumab in hepatocellular carcinoma
-
1:53
richard finn, md: next steps for a uhcc patient with progressive disease
-
1:35
richard finn, md: systemic therapy in a uhcc patient
-
0:36
nevena damjanov, md, on the outcomes of combining atezolizumab with bevacizumab in hcc patients
Clip.africa.com - Privacy-policy